• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Halal Aloe Vera Extract Powder 10:1
Halal Aloe Ferrox Extract powder10:1
BioCana™ Sealer 呼吸袋封口机
BioCana™ SUT 一次性使用生物工艺耗材系统
BioCana™ 超净湿热灭菌防护罩(Tyvek® 1421B)
BioCana™ APS 无菌药用低密度聚乙烯膜/袋

Pfizer Subpoenaed in DOJ Investigation of Drugmaker Charity Connections

firstwordpharmaFebruary 27, 2017

Tag: Pfizer , drugmaker

Pfizer received two subpoenas from the US Attorney’s office in Massachusetts related to charities that help Medicare patients afford co-payments for drugs, Bloomberg reported

  • The company disclosed that it received subpoenas on December 2015 and on July 2016 requesting documents related to the Patient Access Network Foundation and other organisations that provide financial assistance to Medicare patients.

  • "Pfizer is among a number of companies that have received subpoenas regarding this matter," spokeswoman Neha Wadhwa remarked.

  • In 2016, Gilead Sciences, Biogen and Jazz Pharmaceuticals revealed they had received subpoenas for documents related to the nonprofits.

Previous:Sun Pharma: Sun Pharma resets goals, to focus on quality

Next:Merck’s Letermovir, an Investigational Antiviral Medicine for Prevention of Cytomegalovirus (CMV) In

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Pfizer Subpoenaed in DOJ Investigation of Drugmaker Charity Connections | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

PHENOXYMETHYL PENICILLIN POTASSIUM

PHENOXYMETHYL PENICILLIN POTASSIUM
LINCOMYCIN HCL

LINCOMYCIN HCL
GENTAMYCIN SULPHATE macrolides

GENTAMYCIN SULPHATE macrolides
CEFALEXINE cephalosporins

CEFALEXINE cephalosporins
CEFRADINE cephalosporins

CEFRADINE cephalosporins
CEFADROXIL cephalosporins

CEFADROXIL cephalosporins
CEFIXIME cephalosporins

CEFIXIME cephalosporins
CEFATHIAMIDINE cephalosporins

CEFATHIAMIDINE cephalosporins
CEFMINOX SODIUM cephalosporins

CEFMINOX SODIUM cephalosporins
CEFOXITIN SODIUM cephalosporins

CEFOXITIN SODIUM cephalosporins

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service